Cardinal Health (NYSE:CAH) Issues FY 2027 Earnings Guidance

Key Points

• Cardinal Health issued fiscal 2027 adjusted EPS guidance of $12.40–$12.60, above the $12.05 analyst consensus and representing expected growth of roughly 13%–15%.
• The company reported quarterly adjusted EPS of $2.91, beating estimates by $0.49, while revenue rose 6% to $63.67 billion but missed expectations by approximately $1.4 billion.
• Cardinal Health completed $1.4 billion in fiscal 2026 share repurchases, received authorization for an additional $5 billion buyback, and maintained a quarterly dividend of $0.5158 per share.

Cardinal Health (NYSE:CAH - Get Free Report) updated its FY 2027 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 12.400-12.600 for the period, compared to the consensus earnings per share estimate of 12.050. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on CAH. Wells Fargo & Company cut their target price on shares of Cardinal Health from $256.00 to $245.00 and set an "overweight" rating on the stock in a research note on Friday, May 1st. Robert W. Baird set a $248.00 target price on Cardinal Health in a research note on Friday, May 1st. TD Cowen upped their price target on Cardinal Health from $255.00 to $275.00 and gave the stock a "buy" rating in a research note on Thursday, July 9th. Wall Street Zen raised Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, July 4th. Finally, Morgan Stanley upped their target price on Cardinal Health from $245.00 to $255.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 28th. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $251.73.

Cardinal Health Stock Performance

NYSE CAH opened at $236.77 on Tuesday. The company has a market capitalization of $55.45 billion, a PE ratio of 36.20, a price-to-earnings-growth ratio of 1.16 and a beta of 0.49. Cardinal Health has a 52-week low of $137.75 and a 52-week high of $244.87. The company has a 50-day simple moving average of $227.47 and a 200 day simple moving average of $216.44.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, topping the consensus estimate of $2.42 by $0.49. The company had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, analysts forecast that Cardinal Health will post 10.77 EPS for the current fiscal year.

Key Headlines Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Strong earnings beat: Fourth-quarter non-GAAP EPS was $2.91, $0.49 above analyst expectations. Reported non-GAAP EPS increased 40% year over year, while GAAP operating earnings and diluted EPS each rose 70%. Cardinal Health EPS and revenue results
• Positive Sentiment: Above-target fiscal 2027 outlook: Cardinal Health forecast fiscal 2027 non-GAAP EPS of $12.40 to $12.60, representing 13% to 15% growth and exceeding the company’s long-term earnings-growth target. Cardinal Health fiscal 2027 outlook
• Positive Sentiment: Capital returns remain substantial: The company completed $1.4 billion of fiscal 2026 share repurchases, received authorization for an additional $5 billion buyback, and declared a quarterly dividend of $0.5158 per share, payable October 15. Cardinal Health fiscal 2026 results and guidance
• Neutral Sentiment: Financing update: Cardinal Health terminated a five-year revolving credit facility and restructured elements of its credit facilities and financing programs. The change may improve financing flexibility, although the immediate earnings impact is unclear. Cardinal Health credit facilities restructuring
• Negative Sentiment: Revenue missed expectations: Quarterly revenue rose 6% to $63.7 billion but fell approximately $1.4 billion short of consensus estimates near $65.1 billion. With a net margin of only 0.62%, the revenue shortfall and thin profitability remain risks, particularly with CAH trading at a relatively elevated P/E ratio.

Institutional Investors Weigh In On Cardinal Health

Large investors have recently added to or reduced their stakes in the business. Greenline Wealth Management LLC purchased a new position in shares of Cardinal Health during the fourth quarter valued at approximately $89,000. Heritage Wealth Advisors boosted its holdings in Cardinal Health by 31.6% in the fourth quarter. Heritage Wealth Advisors now owns 300 shares of the company's stock worth $62,000 after acquiring an additional 72 shares in the last quarter. Jessup Wealth Management Inc bought a new position in shares of Cardinal Health during the fourth quarter valued at $50,000. Zions Bancorporation National Association UT raised its position in shares of Cardinal Health by 33.8% in the 4th quarter. Zions Bancorporation National Association UT now owns 649 shares of the company's stock worth $133,000 after purchasing an additional 164 shares during the last quarter. Finally, Palisade Asset Management LLC bought a new position in Cardinal Health in the 3rd quarter worth about $47,000. Institutional investors own 87.17% of the company's stock.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source